Peer Reviewed
Perspectives
Glucocorticoid-induced hyperglycaemia: common but easily missed
Abstract
Screening for glucocorticoid-induced hyperglycaemia is important because hyperglycaemia is associated with reduced quality of life, increased rates of infections, poor wound healing, falls and increased long-term risks of macrovascular complications. Management includes general lifestyle modifications, consideration of oral hypoglycaemic agents and/or insulin, and cardiovascular risk factor management.
Key Points
- Glucocorticoid-induced hyperglycaemia is common and the diagnosis is often missed.
- Patients should ideally be screened for pre-existing diabetes before commencing glucocorticoids.
- Blood glucose levels tend to rise postprandially, particularly in the afternoon and evening, in patients taking a morning dose of prednisolone (e.g. in people with chronic obstructive pulmonary disease). Fasting blood glucose levels may be affected in patients taking high doses or long-acting glucocorticoids.
- Screening for glucocorticoid-induced hyperglycaemia should be performed by: – measuring plasma glucose levels two hours after lunch or dinner (11.1 mmol/L or more) – measuring random evening plasma glucose levels (11.1mmol/L or more) – performing a standardised oral glucose tolerance test.
- Asymptomatic patients require two abnormal plasma glucose levels for a definitive diagnosis.
- Measurement of fasting plasma glucose levels has poor sensitivity for diagnosing glucocorticoid-induced hyperglycaemia.
- Management of people with glucocorticoid-induced hyperglycaemia should include general lifestyle modifications, consideration of oral hypoglycaemic agents and/or insulin, and cardiovascular risk factor management.
Get full access
Buy this article
Single article purchases are temporarily unavailable due to site maintenance.
If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.
Thank you for your patience and understanding.
Already a subscriber? Login here.